Related Experiment Video
Updated: May 8, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Cardiovascular involvements in HIV-infected patients
1Intermountain Medical Center, Salt Lake City, UT, USA rami.alharethi@imail.org.
Insights
The lifespan of people with HIV is increasing, leading to more heart disease. Aggressively managing cardiac risk factors and treating heart conditions is vital to reduce deaths in this population.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Increasing lifespan of HIV-infected patients presents new health challenges.
- Cardiovascular diseases (CVD) are emerging as a major comorbidity and cause of death in people with HIV.
- High prevalence of cardiac risk factors and potential impact of antiretroviral therapy (ART) contribute to CVD risk.
Purpose of the Study:
- To highlight the growing burden of cardiovascular diseases in the aging HIV-infected population.
- To emphasize the importance of managing cardiac risk factors in HIV patients.
- To underscore the need for effective cardiovascular disease treatment strategies in this cohort.
Main Methods:
- Review of current literature on HIV, aging, and cardiovascular comorbidities.
- Analysis of epidemiological data regarding mortality causes in HIV-infected individuals.
- Synthesis of evidence on the impact of antiretroviral therapy on cardiovascular health.
Main Results:
- Cardiovascular diseases are a leading cause of death in HIV-infected patients with increased lifespan.
- Prevalence of traditional cardiac risk factors is high in this population.
- Antiretroviral therapy may play a role in the development of cardiovascular complications.
Conclusions:
- Aggressive reduction of cardiac risk factors is crucial for HIV-infected patients.
- Timely and effective treatment of cardiovascular diseases is essential to decrease mortality.
- Integrated care focusing on both HIV management and cardiovascular health is necessary.
Abstract:
The lifespan of HIV-infected patients is increasing, and cardiovascular diseases becoming a major comorbidity and leading cause of death in this population due to high prevalence of the cardiac risk factors and possibly due to the use of antiretroviral therapy. Aggressive reduction of these risk factors and treatment of cardiovascular diseases are crucial to decrease the cardiovascular mortality in these patients.
Related Concept Videos
Sexually Transmitted Infections
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis III: Medical Management
Endocarditis IV: Nursing Management
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Coronary Artery Disease III: Clinical Manifestations
